Alimlieva 500mg Injection

About

Alimlieva 500mg Injection is a broad-spectrum antibiotic belonging to the cephalosporin class, indicated for the treatment of various bacterial infections. It exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to the lysis and death of susceptible bacteria. This injectable formulation ensures rapid systemic distribution, making it effective for severe infections where quick therapeutic levels are crucial. It is active against a wide range of Gram-positive and Gram-negative bacteria, including those resistant to other antibiotics.

Administered intravenously or intramuscularly, Alimlieva is often used in hospital settings for conditions such as complicated urinary tract infections, respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections. Its efficacy and relatively favorable safety profile make it a valuable option in managing serious bacterial pathogens, though careful consideration of patient history and potential for hypersensitivity reactions is essential.

Uses

• Treatment of severe respiratory tract infections
• Management of complicated urinary tract infections
• Therapy for skin and soft tissue infections
• Treatment of intra-abdominal infections

Directions For Use

Alimlieva 500mg Injection is administered by a healthcare professional, typically intravenously or intramuscularly. Dosage and duration depend on the infection type and severity.

Benefits

• Broad-spectrum antibacterial activity
• Rapid onset of action via injection
• Effective against resistant bacterial strains
• Suitable for severe systemic infections
• Good tissue penetration
• Generally well-tolerated

Side Effects

• Injection site pain or inflammation
• Nausea
• Diarrhea
• Vomiting
• Rash
• Headache
• Dizziness
• Abnormal liver function tests
• Eosinophilia
• Thrombocytosis
• Candidiasis
• Allergic reactions (rare but serious)

Safety Measures

• Alcohol - While direct interaction is not common, some cephalosporins can cause a disulfiram-like reaction with alcohol. It's generally advisable to avoid alcohol during treatment with Alimlieva.
• Pregnancy - Alimlieva should be used during pregnancy only if clearly needed and the potential benefits outweigh the risks. Consult your doctor, as animal studies have not shown harm, but human data is limited.
• Breastfeeding - Small amounts of Alimlieva may pass into breast milk. While generally considered safe, monitor the infant for potential side effects like diarrhea or rash. Use with caution.
• Liver - No specific dose adjustment is usually required for mild to moderate liver impairment. However, caution is advised in severe liver disease, and monitoring of liver function is recommended.
• Kidney - Dose adjustment is necessary in patients with significant renal impairment to prevent accumulation and potential toxicity. Your doctor will determine the appropriate dosage based on kidney function.
• Lung - Alimlieva is effective for lung infections and generally does not pose direct risks to lung function. However, severe allergic reactions can impact respiratory status; seek immediate medical attention if breathing difficulties occur.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.